Home › Markets › Health Care › COLL

Collegium Pharmaceutical Inc. (COLL)

COLL trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$21.53
-2.36% on the day
Market cap
$700.9M
Small cap
Revenue · 2025
$780.6M
+23.6% on 2024
Net income · 2025
$63.0M
8.1% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerCOLL on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2015
SEC CIK0001267565
SEC industry codePharmaceutical Preparations
Incorporated inVA

Financials · 2025

LineValue
Revenue$780.6M
Net income$63.0M
Operating income$179.6M
Net margin8.1%
Operating margin23.0%
Revenue growth+23.6%
Cash$231.3M
Total assets$1.7B
P/E (computed)11.1×
P/S (computed)0.9×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-32020-03-16
Latest annual report10-K2026-02-26
Latest quarterly / interim10-Q2026-08-06
Latest current report
FORM 8-K
8-K2026-08-13
Latest proxyDEF 14A2026-04-07

Source: SEC EDGAR submissions feed, 865 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+1.8%
1 month+2.2%
3 months-38.5%
Year to date-51.8%
1 year-30.3%
From 52-week high-55.2%

Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
LXRXLexicon Pharmaceuticals Inc.$1.61-2.42%$716.4M
IMMXImmix Biopharma Inc.$8.69-6.05%$720.4M
IVAInventiva S.A. American Depository Shares$2.87-8.01%$678.1M
ANNXAnnexon Inc.$3.83-3.28%$726.1M
VSTMVerastem Inc.$7.45-9.70%$674.7M
PHARPharming Group N.V. ADS each representing 10$9.44-1.77%$666.7M
OBXObsidian Therapeutics Inc.$11.99-6.25%$740.7M
APMDApnimed Inc.$17.83-4.29%$742.3M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier